Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXC Technology
DXC
|
+$213M |
| 2 |
Altria Group
MO
|
+$206M |
| 3 |
ExxonMobil
XOM
|
+$105M |
| 4 |
Microsoft
MSFT
|
+$86.8M |
| 5 |
Meta Platforms (Facebook)
META
|
+$75.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
YHOO
Yahoo Inc
YHOO
|
+$403M |
| 2 |
Home Depot
HD
|
+$164M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$160M |
| 4 |
Boeing
BA
|
+$127M |
| 5 |
Hewlett Packard
HPE
|
+$92.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.07% |
| 2 | Financials | 16.07% |
| 3 | Healthcare | 14.35% |
| 4 | Industrials | 10.62% |
| 5 | Consumer Discretionary | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3926
Peraso
PRSO
$5.76M
| $41K | ﹤0.01% |
30
-2
| -6% | -$2.09K |
2013 Q2
16 quarters
|
|
|
TGA
3927
DELISTED
Transglobe Energy Corp
TGA
| $41K | ﹤0.01% |
31,199
-7,619
| -20% | -$11.1K |
2013 Q2
16 quarters
|
|
|
SRRA
3928
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $41K | ﹤0.01% |
884
-87
| -9% | -$4.44K |
2015 Q3
7 quarters
|
|
|
SPHS
3929
DELISTED
Sophiris Bio, Inc.
SPHS
| $41K | ﹤0.01% |
19,042
+3,815
| +25% | +$9.34K |
2016 Q3
3 quarters
|
|
3930
DELISTED
CASI Pharmaceuticals
CASI
| $40K | ﹤0.01% |
3,832
-38
| -1% | -$404 |
2014 Q3
11 quarters
|
|
3931
Anixa Biosciences
ANIX
$98.7M
| $39K | ﹤0.01% |
34,351
| – | – |
2015 Q3
7 quarters
|
|
|
CYRN
3932
DELISTED
CYREN Ltd.
CYRN
| $39K | ﹤0.01% |
966
| – | – |
2017 Q1
1 quarter
|
|
3933
DELISTED
Affimed
AFMD
| $38K | ﹤0.01% |
1,876
-468
| -20% | -$10.4K |
2015 Q2
8 quarters
|
|
|
RHE
3934
DELISTED
Regional Health Properties, Inc.
RHE
| $38K | ﹤0.01% |
3,380
| – | – |
2013 Q2
16 quarters
|
|
|
ARLZ
3935
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
| $38K | ﹤0.01% |
28,175
-7,640
| -21% | -$11K |
2016 Q1
5 quarters
|
|
3936
Dare Bioscience
DARE
$14.8M
| $37K | ﹤0.01% |
712
-34
| -5% | -$1.98K |
2014 Q3
11 quarters
|
|
|
FALC
3937
DELISTED
FalconStor Software Inc
FALC
| $37K | ﹤0.01% |
143,545
-7,437
| -5% | -$2.26K |
2013 Q2
16 quarters
|
|
|
HPJ
3938
DELISTED
Highpower International Inc
HPJ
| $37K | ﹤0.01% |
10,264
-1,369
| -12% | -$6.41K |
2017 Q1
1 quarter
|
|
3939
AIM ImmunoTech
AIM
$7.08M
| $37K | ﹤0.01% |
17
| – | – |
2013 Q2
16 quarters
|
|
3940
RF Industries
RFIL
$86.9M
| $36K | ﹤0.01% |
19,760
| – | – |
2013 Q2
16 quarters
|
|
3941
DELISTED
BAIYU Holdings, Inc. Common Stock
BYU
| $35K | ﹤0.01% |
+9
| New | +$25.8K |
2017 Q2
0 quarters
|
|
3942
EDAP TMS S.A.
FOCL
$203M
| $34K | ﹤0.01% |
10,586
-3,497
| -25% | -$9.95K |
2015 Q4
6 quarters
|
|
3943
Oragenics
OGEN
$2.02M
| $33K | ﹤0.01% |
5
| – | – |
2013 Q2
16 quarters
|
|
3944
Viking Therapeutics
VKTX
$3.6B
| $33K | ﹤0.01% |
31,264
| – | – |
2016 Q2
4 quarters
|
|
|
NEPT
3945
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
| $33K | ﹤0.01% |
29
-11
| -28% | -$15.3K |
2014 Q3
11 quarters
|
|
|
DDE
3946
DELISTED
Dover Downs Gaming & Entertain
DDE
| $33K | ﹤0.01% |
30,139
| – | – |
2013 Q2
16 quarters
|
|
|
XPLR
3947
DELISTED
Xplore Technologies Corp.
XPLR
| $33K | ﹤0.01% |
16,945
| – | – |
2015 Q1
9 quarters
|
|
3948
DELISTED
Presbia PLC Ordinary Shares
LENS
| $33K | ﹤0.01% |
14,898
-1
| -0% | -$3 |
2015 Q2
8 quarters
|
|
|
ROKA
3949
DELISTED
Sorrento Tech, Inc. Common Stock
ROKA
| $32K | ﹤0.01% |
12,233
| – | – |
2014 Q3
11 quarters
|
|
|
FAC
3950
DELISTED
First Acceptance Corp.
FAC
| $32K | ﹤0.01% |
28,734
| – | – |
2013 Q2
16 quarters
|
|
Similar funds
Geode Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Geode Capital Management held 4,218 positions worth $254B, up 4.3% from $244B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Geode Capital Management's Q2 2017 filing shows 134 new, 2,755 increased, 887 reduced and 134 closed positions. Its largest new stake was DXC Technology: 3,214,073 shares worth $213M. The largest sale was Yahoo Inc, an estimated $403M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2017 buy was DXC Technology: 3,214,073 shares worth $213M.
- Geode Capital Management added most to Altria Group in Q2 2017, an estimated $206M increase.
- Geode Capital Management's biggest Q2 2017 reduction was Home Depot, cutting an estimated $164M.
- Geode Capital Management fully exited Yahoo Inc in Q2 2017, selling an estimated $403M.
- Geode Capital Management's ten largest holdings make up 16% of its $254B portfolio in Q2 2017.
- Geode Capital Management opened 134 new positions and closed 134 in Q2 2017.
- Geode Capital Management's portfolio value rose 4.3% quarter-over-quarter to $254B.
Based on Geode Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.